ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0951

Epidermal IFNκ Increases Circulating and Cutaneous Monocytes in a C57/Bl6 Overexpression Mouse Model

Patrick O'Brien, Benjamin Klein, Deborah Colesa and J. Michelle Kahlenberg, University of Michigan, Ann Arbor, MI

Meeting: ACR Convergence 2025

Keywords: Cutaneous, interferon, Monocytes/macrophages, Mouse Models, Lupus, neutrophils

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (0934–0954) Systemic Lupus Erythematosus – Animal Models Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Lupus is a heterogeneous inflammatory autoimmune disease affecting a variety of organs, including skin manifestations such as photosensitivity and cutaneous lesions. The skin of human lupus patients is primed for disease through a variety of cellular mechanisms, including an increase in Type I interferons (IFNs) such as interferon kappa (IFNk) that activate immune cells and prime for photosensitivity. Here, we study the effects of epidermal transgenic (Tg) Ifnk overexpression to determine the role of skin-derived type I IFNs in driving lupus phenotypes. This experimental work utilized mice of C57/Bl6 background.

Methods: TgIFNk mice were generated utilizing the K14 promoter to direct Ifnk expression to the basal epidermis as previously reported. Mice were monitored for spontaneous lesions in a 12-month survival cohort. Where indicated, 3-month-old mice were exposed to 300mJ/cm2 UVB 12 hours before euthanasia. Phenotypes of TgIFNk and wild type C57/Bl6 mice were studied via complete blood count (CBC), ELISA, flow cytometry, immunohistochemistry (IHC), immunofluorescence (IF), and quantitative real-time polymerase chain reaction (qrt-PCR) performed on blood, spleen, skin, kidney, and urine harvested at time of euthanasia. All data analysis was performed using GraphPad Prism 10, including two-way ANOVA, one-way ANOVA, or unpaired t-Test where appropriate.

Results: In the C57/Bl6 background, only 4 percent of TgIFNk mice developed spontaneous skin lesions, and no mice developed proteinuria. Lesional mice demonstrated elevated circulating leukocytes compared to age-matched sex-matched non-lesional TgIFNk and WT controls. This increase was driven primarily by an expansion of neutrophils. In the skin, however, immunohistochemistry revealed that skin lesions were enriched primarily in monocytes and monocyte-derived dendritic cells. Non-lesional skin showed no change in CD11b+ cells between genotypes, suggesting that increased circulating neutrophils drive enhanced recruitment of myeloid cells upon cutaneous lesion formation. WT and TgIFNk mice undergoing UVB irradiation exhibited increased monocytes in the skin, but no difference was noted between strains.

Conclusion: TgIFNk mice on the C57/Bl6 background exhibit increases in circulating inflammatory innate immune cells and aggressive myeloid-driven skin disease in a minor subset of mice. Future work seeks to further characterize the function of these innate immune cells in both spontaneous lesions and UVB-mediated disease activation.

Supporting image 1Organ weights (1A-C), Complete blood count (1D), and flow cytometry (1E) of mice generating spontaneous lesions (IfnkTG BL6 skin lesions), and age-matched sex-matched non-lesional TG or wild type (WT) controls illustrating lymphadenopathy, splenomegaly, anemia, increased circulating neutrophils, and increased circulating myeloid cells.

Supporting image 2Immunohistochemistry (IHC) of CD11b and Ly6G for spontaneous lesions (IfnkTG BL6 skin lesions), and age-matched sex-matched non-lesional TG or wild type (WT) controls.

Supporting image 3UVB experiment graphical abstract and flow cytometry results showing a reduction in monocytes in the spleen compared to an increase in monocytes in the skin.


Disclosures: P. O'Brien: None; B. Klein: None; D. Colesa: None; J. Kahlenberg: AstraZeneca, 1, Aurinia Pharmaceuticals, 1, Avion Pharmaceuticals, 1, Biogen, 1, Boehringer-Ingelheim, 1, Bristol-Myers Squibb(BMS), 1, 5, Danger Bio, 1, Eli Lilly, 1, Exo Therapeutics, 2, GlaxoSmithKlein(GSK), 2, Janssen, 5, Provention Bio, 1, Q32 Bio, 5, Rome Therapeutics, 2, 5, Ventus, 2, 5.

To cite this abstract in AMA style:

O'Brien P, Klein B, Colesa D, Kahlenberg J. Epidermal IFNκ Increases Circulating and Cutaneous Monocytes in a C57/Bl6 Overexpression Mouse Model [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/epidermal-ifn%ce%ba-increases-circulating-and-cutaneous-monocytes-in-a-c57-bl6-overexpression-mouse-model/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/epidermal-ifn%ce%ba-increases-circulating-and-cutaneous-monocytes-in-a-c57-bl6-overexpression-mouse-model/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology